Neonatal monosodium glutamate treatment modifies glutamic acid decarboxylase activity during rat brain postnatal development

Neurochemistry International

Volumn 42, Issue 4, 2003, Pages 269-276

  Ureña Guerrero, Mónica Elisa ^a   López Pérez, Silvia Josefina ^a   Beas Zárate, Carlos ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

Development; Excitotoxicity; GABA; GAD; Glutamate

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPTIC POTENTIAL; VELOCITY;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; BRAIN; CEREBELLUM; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; KINETICS; NEOSTRIATUM; ORGAN SIZE; PREGNANCY; RATS; SODIUM GLUTAMATE;

EID: 0037333031     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00131-6     Document Type: Article

References (58)

1. Abramova M.A., Calas A., Mailly P., Thibault J., Ugryumov M.V. The responses of vasopressin- and tyrosine hydroxylase-expressing neurons of the supraoptic nucleus in rats to chronic osmotic stimulation. Neurosci. Behav. Physiol. 30:2000;617-624.
2. Alexi T., Borlongan C.V., Faull R.L.M., Williams C.E., Clark R.G., Gluckman P.D., Hughes P.E. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog. Neurobiol. 60:2000;409-470.
3. Balcar V.J., Zetzsche T., Wolff J.R. Glutamate decarboxylase in developing rat neocortex: does it correlate with the differentiation of GABAergic neurons and synapses? Neurochem. Res. 17:1992;253-260.
4. Beas-Zárate C., Sánchez-Ruíz M.Y., Ureña-Guerrero M.E., Feria-Velasco A. Effect of perinatal administration of monosodium L-glutamate to young rats on GABA release from various cerebral regions during postnatal development. Neurochem. Int. 33:1998;217-232.
5. Beas-Zárate C., Rivera-Huizar S.V., Martínez-Contreras A., Feria-Velasco A., Armendáriz-Borunda J. Changes in NMDA-receptor gene expression are associated with neurotoxicity induced neonatally by glutamate in the rat brain. Neurochem. Int. 39:2001;1-10.
6. Beas-Zárate C., Flores-Soto M.E., Armendariz-Borunda J. NMDAR-2C and -2D subunits gene expression is induced in brain by neonatal exposure of monosodium L-glutamate to adult rats. Neurosci. Lett. 321:2002;9-12.
7. Beas-Zárate, C., Pérez-Vega, M.I., González-Burgos, I., 2002. Neonatal exposure to monosodium L-glutamate induces cell death and cytoarchictural impairments in hippocampal CA1 pyramidal neurons of adult rats. Brain Res., in press.
8. Behar T.N., Li Y.X., Tran H.T., Ma W., Dunlap V., Scott C., Barket J.L. GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J. Neurosci. 16:1996;1808-1818.
9. Ben-Ari Y. Developing networks play a similar melody. Trends Neurosci. 24:2001;353-360.
10. Bitoun M., Tappaz M. Gene expression of taurine transporter and taurine biosynthetic enzymes in hyperosmotic states: a comparative study with the expression of the genes involved in the accumulation of other osmolytes. Adv. Exp. Med. Biol. 483:2000;239-248.
11. Canepari M., Mammano F., Kachalsky S.G., Rahamimoff R., Cherubini E. GABA- and glutamates-mediated network activity in the hippocampus of neonatal and juvenile rats revealed by fast calcium imaging. Cell Calcium. 27:2000;25-33.
12. Carbonell W.S., Grady M.S. Evidence disputing the importance of excitotoxicity in hippocampal neuron death after experimental traumatic brain injury. Ann. N. Y. Acad. Sci. 890:1999;287-298.
13. Chen K.C., Nicholson C. Changes in brain cell shape create residual extracellular space volume and explain tortuosity behaviour during osmotic challenge. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8306-8311.
14. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
15. De Almeida O.M.M.S., Gardino P.F., Loureriro dos Santos N.E., Yamasaki E.N., de Mello M.C.F., Hokoc J.N., de Mello F.G. Opposite roles of GABA and excitatory amino acids on the control of GAD expression in cultured retina cells. Brain Res. 925:2002;89-99.
16. Di Giorgio R.M., De Luca G.C., Garofalo M.P., Conti C., Ientile R. GABAergic system in brain regions of glutamate-lesioned rats. Ital. J. Biochem. 34:1985;19-28.
17. Erlander M.G., Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem. Res. 16:1991;215-226.
18. Esclapez M., Houser C.R. Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy. J. Comp. Neurol. 412:1999;488-505.
19. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42:1984;1-11.
20. Golarai G., Greenwood A.C., Feeney D.M., Connor J.A. Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury. J. Neurosci. 21:2001;8523-8537.
21. Gonzales C., Lin R.C., Chesselet M.F. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neurosci. Lett. 135:1992;53-58.
22. Gonzalez-Burgos I., Perez-Vega I., Beas-Zarate C. Neonatal exposure to monosodium glutamate induces cell death and dendritic hypotrophy in rat prefrontocortical pyramidal neurons. Neurosci. Lett. 297:2001;69-72.
23. Gubellini P., Ben-Ari Y., Gaïarsa J.L. Activity- and age-dependent GABAergic synaptic plasticity in the developing rat hippocampus. Eur. J. Neurosci. 14:2001;1937-1946.
24. Hicks C.A., Ward M.A., Swettenham J.B., O'Neil M.J. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitor in global cerebral ischaemia. Eur. J. Pharmacol. 381:1999;113-119.
25. 3H ] estradiol Brain Res. 308:1984;245-253.
26. Kalda A., Kaasik A., Vassilje V., Pokk P., Zharkovsky A. Neuroprotective action of I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death. Brain Res. 853:2000;370-373.
27. Kawa K. Acute synaptic modulation by nicotinic agonists in developing cerebellar Purkinje cells of the rat. J. Physiol. 538:2002;87-102.
28. Kuppers E., Sabolek M., Anders U., Pilgrim C., Beyer C. Developmental regulation of glutamic acid decarboxylase mRNA expression and splicing in the rat striatum by dopamine. Mol. Brain Res. 81:2000;19-28.
29. Leifer D., Kowall N.W. Immunohistochemical patterns of selective cellular vulnerability in human ischemia. J. Neurol. Sci. 119:1993;217-228.
30. Lowry O., Rosenbrough N., Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
31. Luk K.C., Sadikot A.F. GABA promotes survival but not proliferation of parvalbumin-immunoreactive interneurons in rodent neostriatum: an in vivo study with stereology. Neuroscience. 104:2001;93-103.
32. Martin D.L., Rimvall K. Regulation of γ-aminobutyric acid synthesis in the brain. J. Neurochem. 60:1993;395-407.
33. Martin L.J., Al-Abdulla N.A., Brambrik A.M., Kirsch J.R., Sieber F.E., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contribution of apoptosis and necrosis. Brain Res. Bull. 4:1998;281-309.
34. Marty S., Wehrle R., Sotelo C. Neuronal activity and brain-derived neurotrophic factor regulate the density of inhibitory synapses in organotypic slice culture of postnatal hippocampus. J. Neurosci. 20:2000;8087-8095.
35. McLean H.A., Caillard O., Ben-Ari Y., Gaiarsa J.L. Bidirectional plasticity expressed by GABAergic synapses in the neonatal rat hippocampus. J. Physiol. 496:1996;471-477.
36. Michaelis E.K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54:1998;369-415.
37. Muller G.J., Moller A., Johansen F.F. Stereological cell counts of GABAergic neurons in rat dentate hilus following transient cerebral ischemia. Exp. Brain Res. 141:2001;380-388.
38. Obenaus A., Esclapez M., Houser C.R. Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures. J. Neurosci. 13:1993;4470-4485.
39. Obrenovitch T.P., Urenjak J., Zilka E., Jay T.M. Excitotoxicity in neurological disorders - the glutamate paradox. Int. J. Dev. Neurosci. 18:2000;281-287.
40. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
41. Ortuño-Sahagun D., Beas-Zárate C., Adame-González G., Feria-Velasco A. Effect of L-glutamate on cholinergic neurotransmission in various brain regions during the development of rats, when administered perinatally. Neurochem. Int. 31:1997;683-692.
42. Portera-Cailliau C., Price D.L., Martin L.J. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol. 378:1997;70-87.
43. Reeves T.M., Lyeth B.G., Phillips L.L., Hamm R.J., Povlishock J.T. The effects of traumatic brain injury on inhibition in the hippocampus and dentate gyrus. Brain Res. 757:1997;119-132.
44. 3H ] flunitrazepam binding after postnatal monosodium glutamate injections in rats J. Pharmacol. Exp. Ther. 218:1981;791-796.
45. Ribak C.E., Roberts R.C. GABAergic synapses in the brain identified with antisera to GABA and its synthesizing enzyme, glutamate decarboxylase. J. Electron Microsc. Tech. 15:1990;34-48.
46. Robinson M.B., Coyle J.T. Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J. 1:1987;446-455.
47. Romijn H.J., van Marle J., Janszen A.W.J.W. Permanent increase of the GAD67/synaptophysin ratio in rat cerebral cortex nerve endings as a result of hypoxic ischemia encephalopathy sustained in early postnatal life: a confocal laser scanning microscopic study. Brain Res. 630:1993;315-329.
48. Schwarzer C., Sperk G. Hippocampal granule cells express glutamic acid decarboxylase-67 after limbic seizures in the rat. Neuroscience. 69:1995;705-709.
49. Seress L., Ribak C.E. The development of GABAergic neurons in the rat hippocampal formation. An immunocytochemical study. Dev. Brain Res. 44:1988;197-209.
50. Sheikh S.N., Martin S.B., Martin D.L. Regional distribution and relative amounts of glutamate decarboxylase isoforms in rat and mouse brain. Neurochem. Int. 35:1999;73-80.
51. Soria J.M., Martínez-Galan J.R., Lujan R., Valdeolmillos M., Fairen A. Functional NMDA and GABAA receptors in pioneer neurons of the cortical marginal zone. Eur. J. Neurosci. 11:1999;3351-3354.
52. Sun Y.M., Hsu H.K., Lue S.I., Peng M.T. Sex-specific impairment in sexual and ingestive behaviors of monosodium glutamate-treated rats. Physiol. Behav. 50:1991;873-880.
53. Szabo G., Kartarova Z., Hoertnagl B., Somogyi R., Sperk G. Differential regulation of adult and embryonic glutamate decarboxylases in rat dentate granule cells after kainite-induced limbic seizures. Neuroscience. 100:2000;287-295.
54. Tapia R., Salazar P. Glutamate decarboxylase activity in the substantia nigre and the hippocampus of rats microinjected with inhibitor of the enzyme. Neurochem. Res. 16:1991;263-267.
55. Tortosa A., Ferrer I. Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischaemia: a qualitative and quantitative sequential study. Neuroscience. 55:1993;33-43.
56. Vincent S.L., Pabreza L., Benes F.M. Postnatal maturation of GABA-immunoreactive neurons of rat medial prefrontal cortex. J. Comp. Neurol. 355:1995;81-92.
57. Zhang W.M., Kuchar S., Mozes S. Body fat and RNA content of the VMH cells in rats neonatally treated with monosodium glutamate. Brain Res. Bull. 35:1994;383-385.
58. Wang K., Guldenaar S.E., McCabe J.T. Fos and Jun expression in rat supraoptic nucleus neurons after acute versus repeated osmotic stimulation. Brain Res. 746:1997;117-125.